significant

CATL Chairman and CEO Robin Zeng Outlines Vision for Global Zero-Carbon Transition and Deeper Collaboration at Major Conference

CHENGDU, China, June 23, 2025 /PRNewswire/ -- Recently, Dr. Robin Zeng, Chairman and CEO of Contemporary Amperex Technology Co., Limited (CATL), delivered…

5 months ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of…

5 months ago

Knest Onboards Lighthouse Funds as a Strategic Partner, Secures a landmark 300 Crore Backing

PUNE, India, June 20, 2025 /PRNewswire/ -- In a move that underscores the rising global confidence in India's construction technology…

5 months ago

BAY Miner Launches Next-Gen Mobile Crypto Mining App with Multilingual Support to Drive Global Adoption

Miami, Florida, June 19, 2025 (GLOBE NEWSWIRE) -- BAY Miner has officially announced the launch of its new mobile mining application…

5 months ago

Ferguson Launches Global Capability Center Powered by ANSR in Bengaluru

BENGALURU, India, June 19, 2025 /PRNewswire/ -- Ferguson, the largest value-added distributor serving the specialized professional in their $340B residential…

5 months ago

New Research Ranks Quora as the #1 Most-Cited Website in Google AI Overviews

Semrush study signals Quora's significant role in the AI-powered search journey MUMBAI, India and MOUNTAIN VIEW, Calif., June 19, 2025…

5 months ago

AlphaGrep Receives In-Principle Approval from SEBI to Sponsor Mutual Fund

MUMBAI, India, June 19, 2025 /PRNewswire/ -- AlphaGrep Securities, a leading quantitative investment firm specializing in systematic strategies, is pleased…

5 months ago

Tongji Day and Tongji-German Symposium 2025 Shapes Sino-European Green Collaboration

BERLIN, June 17, 2025 /PRNewswire/ -- Tongji Day and Tongji-German Symposium 2025 was successfully held in Berlin on June 13,…

5 months ago

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025

June 14, 2025 10:48 ET  | Source: Celldex Therapeutics, Inc. 77% of patients (150 mg Q4W) treated with barzolvolimab who…

5 months ago

Prime Success Responds to Sinovac Biotechs False and Misleading Claims

For More Information, Visit www.SaveSinovac.comHONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder…

5 months ago